Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Erik P Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet, Mark H. Kawachi, Simon Kim, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. MorganKelvin A. Moses, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenkle, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Deborah A. Freedman-Cass

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

Original languageEnglish (US)
Pages (from-to)509-519
Number of pages11
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number5
StatePublished - May 1 2016

Fingerprint

Prostatic Neoplasms
Guidelines
Biopsy
Unnecessary Procedures
Early Detection of Cancer
Practice Guidelines
African Americans
Patient Selection
Mutation
Population

ASJC Scopus subject areas

  • Oncology

Cite this

Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Castle, E. P., Catalona, W. J., ... Freedman-Cass, D. A. (2016). Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 14(5), 509-519.

Prostate cancer early detection, Version 2.2016 : Featured updates to the NCCN guidelines. / Carroll, Peter R.; Parsons, J. Kellogg; Andriole, Gerald; Bahnson, Robert R.; Castle, Erik P; Catalona, William J.; Dahl, Douglas M.; Davis, John W.; Epstein, Jonathan I.; Etzioni, Ruth B.; Farrington, Thomas; Hemstreet, George P.; Kawachi, Mark H.; Kim, Simon; Lange, Paul H.; Loughlin, Kevin R.; Lowrance, William; Maroni, Paul; Mohler, James; Morgan, Todd M.; Moses, Kelvin A.; Nadler, Robert B.; Poch, Michael; Scales, Chuck; Shaneyfelt, Terrence M.; Smaldone, Marc C.; Sonn, Geoffrey; Sprenkle, Preston; Vickers, Andrew J.; Wake, Robert; Shead, Dorothy A.; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, No. 5, 01.05.2016, p. 509-519.

Research output: Contribution to journalArticle

Carroll, PR, Parsons, JK, Andriole, G, Bahnson, RR, Castle, EP, Catalona, WJ, Dahl, DM, Davis, JW, Epstein, JI, Etzioni, RB, Farrington, T, Hemstreet, GP, Kawachi, MH, Kim, S, Lange, PH, Loughlin, KR, Lowrance, W, Maroni, P, Mohler, J, Morgan, TM, Moses, KA, Nadler, RB, Poch, M, Scales, C, Shaneyfelt, TM, Smaldone, MC, Sonn, G, Sprenkle, P, Vickers, AJ, Wake, R, Shead, DA & Freedman-Cass, DA 2016, 'Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 5, pp. 509-519.
Carroll, Peter R. ; Parsons, J. Kellogg ; Andriole, Gerald ; Bahnson, Robert R. ; Castle, Erik P ; Catalona, William J. ; Dahl, Douglas M. ; Davis, John W. ; Epstein, Jonathan I. ; Etzioni, Ruth B. ; Farrington, Thomas ; Hemstreet, George P. ; Kawachi, Mark H. ; Kim, Simon ; Lange, Paul H. ; Loughlin, Kevin R. ; Lowrance, William ; Maroni, Paul ; Mohler, James ; Morgan, Todd M. ; Moses, Kelvin A. ; Nadler, Robert B. ; Poch, Michael ; Scales, Chuck ; Shaneyfelt, Terrence M. ; Smaldone, Marc C. ; Sonn, Geoffrey ; Sprenkle, Preston ; Vickers, Andrew J. ; Wake, Robert ; Shead, Dorothy A. ; Freedman-Cass, Deborah A. / Prostate cancer early detection, Version 2.2016 : Featured updates to the NCCN guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2016 ; Vol. 14, No. 5. pp. 509-519.
@article{c3f23fbdd7be4e6488e40e835e3452a5,
title = "Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines",
abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.",
author = "Carroll, {Peter R.} and Parsons, {J. Kellogg} and Gerald Andriole and Bahnson, {Robert R.} and Castle, {Erik P} and Catalona, {William J.} and Dahl, {Douglas M.} and Davis, {John W.} and Epstein, {Jonathan I.} and Etzioni, {Ruth B.} and Thomas Farrington and Hemstreet, {George P.} and Kawachi, {Mark H.} and Simon Kim and Lange, {Paul H.} and Loughlin, {Kevin R.} and William Lowrance and Paul Maroni and James Mohler and Morgan, {Todd M.} and Moses, {Kelvin A.} and Nadler, {Robert B.} and Michael Poch and Chuck Scales and Shaneyfelt, {Terrence M.} and Smaldone, {Marc C.} and Geoffrey Sonn and Preston Sprenkle and Vickers, {Andrew J.} and Robert Wake and Shead, {Dorothy A.} and Freedman-Cass, {Deborah A.}",
year = "2016",
month = "5",
day = "1",
language = "English (US)",
volume = "14",
pages = "509--519",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "5",

}

TY - JOUR

T1 - Prostate cancer early detection, Version 2.2016

T2 - Featured updates to the NCCN guidelines

AU - Carroll, Peter R.

AU - Parsons, J. Kellogg

AU - Andriole, Gerald

AU - Bahnson, Robert R.

AU - Castle, Erik P

AU - Catalona, William J.

AU - Dahl, Douglas M.

AU - Davis, John W.

AU - Epstein, Jonathan I.

AU - Etzioni, Ruth B.

AU - Farrington, Thomas

AU - Hemstreet, George P.

AU - Kawachi, Mark H.

AU - Kim, Simon

AU - Lange, Paul H.

AU - Loughlin, Kevin R.

AU - Lowrance, William

AU - Maroni, Paul

AU - Mohler, James

AU - Morgan, Todd M.

AU - Moses, Kelvin A.

AU - Nadler, Robert B.

AU - Poch, Michael

AU - Scales, Chuck

AU - Shaneyfelt, Terrence M.

AU - Smaldone, Marc C.

AU - Sonn, Geoffrey

AU - Sprenkle, Preston

AU - Vickers, Andrew J.

AU - Wake, Robert

AU - Shead, Dorothy A.

AU - Freedman-Cass, Deborah A.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.

UR - http://www.scopus.com/inward/record.url?scp=84968764427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968764427&partnerID=8YFLogxK

M3 - Article

C2 - 27160230

AN - SCOPUS:84968764427

VL - 14

SP - 509

EP - 519

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 5

ER -